Dear Fellow Investor,
As a valued Inside China Dispatch subscriber, I want to tell you a secret. A secret that I'm only telling my China Strategy subscribers -- but because the opportunity is so great, I don't want you to miss out.
Ok, so maybe it's not that big of a secret that earnings are important. Actually, they're extremely important if you want to double your money in China. Because if you know the earnings potential of a company, you take out the risk and you're just left with the profits -- lots and lots of profits.
| Olympic Wrap-up |
|
Excited about what you saw in happen in Beijing during the 2008 Summer Olympics? But not sure what's up next for China post-Olympics? Well, you're in luck. In next week's Inside China Dispatch, I'm going to review the Beijing Olympics -- from the Opening Ceremonies to Michael Phelps' eight gold medals to the Chinese divers' dominance to the Closing Ceremony. I observed the final days of the Olympics firsthand in Beijing. And now that I've returned to the States, I have a wealth of knowledge about China's current economic state, and I want to share what I expect from the country through the end of the year. Be sure to tune back in next week! In the meantime, be sure to check out InvestorPlaceAsia for my up-to-the-minute updates on what's happening in China. |
My China Strategy subscribers can testify to this. Back in mid-July, I advised my readers to load up on China's leading education services company before their earnings announcement. What was I expecting? Big results.
Was I right? Oh, yeah!
This education company exceeded expectations, reporting that its revenue grew nearly 63% from the same quarter in 2007, with revenue from educational programs and services growing 61%. And for fiscal 2008, its income clocked in 71% higher than last year.
How'd the stock react to such positive results? It gained 11% in five days following the earnings announcement. And my China Strategy subscribers now have more than a 200% gain in the company.
Don't Miss the Next 10% Gainer!
Now here's the real secret: One of my favorite Chinese companies -- the number-one medical devices manufacturer in China -- is reporting earnings on September 3. And you're going to want to be on board before that announcement hits the airwaves.
This company has been benefiting from the three biggest socio-economic trends of the 21st century: 1) China's economic emergence and healthcare reform; 2) the graying of the population in developed countries; and 3) rising healthcare costs around the globe.
The market for high-quality medical care is always strong -- especially now. With baby boomers on the verge of retirement and the Chinese now able to spend more money on healthcare, this company has been raking in the profits. It's been so successful because it's the world's leading, low-cost producer of high-quality medical devices, selling its products in over 120 countries.
And because this company operates in a large and booming market, it delivers superior and consistent earnings growth. Just look at the past two quarters:
Back in March, this company reported solid earnings for the fourth quarter and fiscal 2007 and easily beat Wall Street's estimates. Its net income for 2007 increased an impressive 64%, and net revenues jumped 47%. And sales increased both home and abroad, climbing 42% in China and 53% in international markets.
And then in the most recent quarter, the company announced blowout first-quarter earnings. Revenues increased nearly 50% from the same quarter in 2007, with revenues in international markets jumping 49% and in China increasing 47%.
As you might have guessed, the stock responded positively to the results -- jumping 12% in one day!
You Must Act Now!
And I'm expecting the company to do it again. Since I recommended this medical devices company back in October 2006, my subscribers have banked a nice 144% gain.
Profits like this aren't easy to come by these days – as the world's markets' volatility has wrecked havoc on investors' portfolios worldwide. So when you come across a fundamentally strong company in a booming industry -- and it's consistently exceeding analysts' expectations -- you need to grab it.
This company can deliver steady, long-term growth of more than 40%, even in the current slowing economic environment. And I don't want you to miss the handfuls of profits to be made in it.
And if you buy in now before the company announces earnings on September 3, you'll likely jumpstart your investment with a nice 10% gain in five days. To learn how you can profit from this medical devices company, join China Strategy today!
Robert Hsu





